#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Graft versus host disease Vascular calcification Acute lymphocytic leukaemia Congenital hypotransferrinaemia Extra-osseous Ewing's sarcoma recurrent Haemophilia A without inhibitors Biliary cancer metastatic Splenic marginal zone lymphoma Epileptic encephalopathy Familial dilated cardiomyopathy Marginal zone lymphoma refractory Neuroendocrine cell hyperplasia of infancy Marginal zone lymphoma recurrent Pericarditis Canavan disease More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Basic Information Combined immunodeficiency – Treatment Medulloblastoma – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Familial haemophagocytic lymphohistiocytosis – Basic Information Pituitary-dependent Cushing’s syndrome – Diagnostics Basal cell naevus syndrome – Life with Disease Wolfram syndrome Pituitary-dependent Cushing’s syndrome – Trials in Disease Langerhans’ cell histiocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Andexanet Alfa Vorinostat Pramlintide Acetate Relatlimab Dorzolamide Pp1493 Nortriptyline Utreloxastat Nicotinamide Bp Phenylalanine Sar444656 Everolimus Ucp4 Jnj-77242113 Cobimetinib Glutathione Ambroxol Hydrochloride Edg-5506 Pehero Propranolol More therapies…

    Learn about Your Condition

    Eructation Hereditary optic atrophy Factor IX deficiency Skin cancer Asplenia Spinal cord injury Proteus syndrome Peptostreptococcus infection Endolymphatic hydrops Diabetic foot Procedural pain Metastatic neoplasm Mucopolysaccharidosis Post-traumatic headache Testicular germ cell tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Oxytocin Nasal Spray for Patients with Central Diabetes Insipidus

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetes insipidus
    Germany The Netherlands

  • Study on the Safety of Self-Infusion Therapy with Human Alpha1-Proteinase Inhibitor for Patients with Severe Alpha-1 Antitrypsin Deficiency

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    Germany

  • Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients 55+ with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Ponatinib
    • Blinatumomab
    • Imatinib
    Finland France Sweden

  • Study on Bevacizumab and Dexamethasone for Treating Brain Radiation Damage in Patients with High-Grade Glioma or Brain Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Bevacizumab
    The Netherlands

  • Study on Tedopi and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer After Initial Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    France Italy Spain

  • Study on Enfortumab Vedotin for Patients with Advanced Neuroendocrine Carcinoma Not Responding to or Ineligible for Platinum Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    Investigated Drugs:
    • Enfortumab Vedotin
    Spain
Previous Page
1 … 283 284 285 286 287 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!